Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS

Submitted by admin on October 25, 2023 - 9:41am

Source:

BioSpace

News Tags:

Servier

Tibsovo

MDS

FDA

Headline:

Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS

snippet:

The FDA on Tuesday gave Servier’s Tibsovo (ivosidenib tablets) an additional indication, allowing its use in patients with relapsed or refractory myelodysplastic syndromes carrying a susceptible IDH1 mutation.

Search form

You are here

Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS

Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS